S2 Episode 5: HIV, Primary Care Treatment, and Vaccines S2 Episode 5: HIV, Primary Care Treatment, and Vaccines
Drs Michael S. Saag and David H. Spach discuss HIV and the nuances of primary care treatment, with a special focus on vaccines, including COVID, hepatitis, varicella zoster virus, and mpox.Medscape (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - July 13, 2023 Category: Infectious Diseases Tags: HIV/AIDS InDiscussion Source Type: news
Tuberculosis: A Disease of the Poor Begs For Rich Funding
A public awareness banner about tuberculosis on a fence in the Hope Fountain area, Bulawayo, Zimbabwe. Credit: Busani Bafana/IPSBy Busani BafanaBULAWAYO, Jul 3 2023 (IPS) The United Nations General Assembly is convening a high-level meeting on Tuberculosis (TB) to get a political commitment for increased funding for programmes and research to end an old disease that today kills more people than AIDS and COVID.
TB, an infectious disease caused by Mycobacterium tuberculosis, kills 1.5 million people annually, according to the World Health Organization (WHO). Despite being curable at a relatively low cost, TB has remained a h...
Source: IPS Inter Press Service - Health - July 3, 2023 Category: International Medicine & Public Health Authors: Busani Bafana Tags: Africa Development & Aid Editors' Choice Featured Global Health Humanitarian Emergencies Inequality Innovation Sustainable Development Goals TerraViva United Nations IPS UN Bureau IPS UN Bureau Report World Health Organisation (W Source Type: news
Ethnic Disparities in Mpox Cases and Vaccination Among Males Ethnic Disparities in Mpox Cases and Vaccination Among Males
This report examines the racial and ethnic disparities in mpox incidence and vaccination rates among adult males in the United States during the current mpox outbreak.Morbidity & Mortality Weekly Report (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - June 23, 2023 Category: Infectious Diseases Tags: Public Health & Prevention Journal Article Source Type: news
Roche awarded WHO prequalification for the cobas ® HPV test, increasing access to cervical cancer screening tools in low and lower-middle income countries
Every year, over 600,000 women worldwideare diagnosed with cervical cancer and over 340,000 die from this preventable disease, caused by infection with human papillomavirus (HPV). Nine out of 10 women who die from cervical cancer live in low- and lower-middle income countries (LMICs).1WHO prequalification enables LMICs to use thecobas® HPV test in their national cervical cancer elimination programs, increasing access to the patients who need it most.Establishing screening programs helps prevent and detect cervical cancer, which is especially important in areas with limited healthcare resources where patientsare often diag...
Source: Roche Media News - June 13, 2023 Category: Pharmaceuticals Source Type: news
Roche awarded WHO prequalification for the cobas ® HPV test, increasing access to cervical cancer screening tools in low and lower-middle income countries
Every year, over 600,000 women worldwideare diagnosed with cervical cancer and over 340,000 die from this preventable disease, caused by infection with human papillomavirus (HPV). Nine out of 10 women who die from cervical cancer live in low- and lower-middle income countries (LMICs).1WHO prequalification enables LMICs to use thecobas® HPV test in their national cervical cancer elimination programs, increasing access to the patients who need it most.Establishing screening programs helps prevent and detect cervical cancer, which is especially important in areas with limited healthcare resources where patientsare often diag...
Source: Roche Investor Update - June 13, 2023 Category: Pharmaceuticals Source Type: news
EU Approves Its First Vaccine for Common Respiratory Virus RSV EU Approves Its First Vaccine for Common Respiratory Virus RSV
European regulators have approved the region ' s first vaccine for respiratory syncytial virus, which causes thousands of hospitalizations and deaths annually.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - June 9, 2023 Category: Infectious Diseases Tags: Pulmonary Medicine News Source Type: news
Advances in HIV Vaccine Research Show Promise for Prevention Advances in HIV Vaccine Research Show Promise for Prevention
In their search for an effective HIV vaccine, researchers have explored several platforms and targets to generate a robust immune response.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - June 8, 2023 Category: Internal Medicine Tags: HIV/AIDS News Source Type: news
Possible Mpox Protection From Smallpox Vaccine Antibodies Possible Mpox Protection From Smallpox Vaccine Antibodies
Could the antibodies generated by the smallpox vaccine help protect against the mpox virus?Emerging Infectious Diseases (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - June 8, 2023 Category: Infectious Diseases Tags: Infectious Diseases Journal Article Source Type: news
Close Inequalities to End AIDS & Prepare for Future Pandemics
Thembeni Mkingofa, a woman living with HIV, visits the PMTCT section of the Makhume District Hospital, Zimbabwe. She has three children - 14, 10 and 2 who are all HIV negative. This is her fourth pregnancy. Her husband is also on HIV treatment. Here she is pictured with her two-year-old daughter, Hilda Chakiryizira. 5 November 2019. Credit: UNAIDS/C. MatonhodzeBy Winnie Byanyima and Sir Michael MarmotBRASILIA, Brazil, Jun 5 2023 (IPS) The COVID-19 crisis has shone a light on the danger of pandemics; social crises have shone a light on the danger of inequalities. And the reality is that outbreaks become the pandemics they d...
Source: IPS Inter Press Service - Health - June 5, 2023 Category: International Medicine & Public Health Authors: Winnie Byanyima and Sir Michael Marmot Tags: Africa COVID-19 Development & Aid Editors' Choice Featured Headlines Health Inequity Latin America & the Caribbean Poverty & SDGs TerraViva United Nations IPS UN Bureau Source Type: news
Researchers use ‘natural’ system to identify proteins most useful for developing an effective HIV vaccine
Since it was identified in 1984 as the cause of Acquired Immune Deficiency Syndrome (AIDS), the human immunodeficiency virus (HIV) has infected more than 80 million people and been responsible for some 40 million deaths worldwide, according to the World Health Organization (WHO). Currently, the WHO reports more than 38 million people globally live with the retrovirus, and each year, another 1 million new cases are diagnosed. (Source: World Pharma News)
Source: World Pharma News - May 30, 2023 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Risk for Mpox Resurgence Rises Risk for Mpox Resurgence Rises
With the return of summer festivals, public health experts are renewing calls for mpox vaccination and prevention efforts.CDC Expert Commentary (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - May 18, 2023 Category: Infectious Diseases Tags: Infectious Diseases Commentary Source Type: news
Reps. Bera, Kiggans Introduce Bipartisan Global Frontline Health Workers Resolution
This article is based on thepost published on the Frontline Health Workers Coalition blog authored by Carol Bales of IntraHealth and Corinne Paul of CARE USA. (Source: IntraHealth International)
Source: IntraHealth International - May 15, 2023 Category: International Medicine & Public Health Authors: cbales Tags: Health workforce development Policy & Advocacy Health Workers Nurses Source Type: news
Can a Pledge to End TB Stick This Time Around?
In India, a doctor checks a patient’s x-ray for lung damage, which may indicate tuberculosis. Credit: ILO/Vijay Kuty
On May 8, there will be an interactive multistakeholder hearing at the UN as part of the preparatory process toward High-level meeting on the fight against tuberculosis. The event will be broadcast live on UN Web TV.
Meanwhile, the head of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus, has unveiled plans to speed up the licensing and use of effective novel vaccines against tuberculosis (TB), the second leading infectious killer after COVID-19 and the 13th leading cause o...
Source: IPS Inter Press Service - Health - May 8, 2023 Category: International Medicine & Public Health Authors: Morounfolu Olugbosi Tags: Development & Aid Editors' Choice Featured Global Headlines Health Human Rights Humanitarian Emergencies TerraViva United Nations IPS UN Bureau Source Type: news
Tuberculosis Risk Factors Exacerbated by Climate Change
A doctor talks to a TB survivor at a clinic in Manilla,
Philippines. Credit: Getty Images for TB Alliance
By Ed HoltBRATISLAVA, May 2 2023 (IPS) While there is no established causal relationship between climate change and tuberculosis (TB), studies have begun to highlight the potential impact its effects could have on the spread of the disease.
Undernutrition, HIV/AIDS, overcrowding, poverty, and diabetes have all been identified as TB risk factors that are worsened by climate change. Worryingly, many countries with high burdens of TB, including, for instance, drought-hit Ethiopia, Indonesia, Kenya, and Peru, have suffered...
Source: IPS Inter Press Service - Health - May 2, 2023 Category: International Medicine & Public Health Authors: Ed Holt Tags: Climate Change Development & Aid Editors' Choice Featured Global Headlines Health Human Rights Humanitarian Emergencies Migration & Refugees TerraViva United Nations IPS UN Bureau IPS UN Bureau Report tuberculosis (TB) Source Type: news
ACIP 2023 Recommended Immunization Schedule for Adults ACIP 2023 Recommended Immunization Schedule for Adults
Review vaccine-specific changes in the 2023 immunization schedule for adults aged 19 years and older, including updates to influenza, hepatitis B, and pneumococcal vaccination.Morbidity & Mortality Weekly Report (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - April 24, 2023 Category: Infectious Diseases Tags: Public Health & Prevention Journal Article Source Type: news
